Topical therapy and the development of silver sulfadiazine.
Topical therapy is a selective approach to the prevention and treatment of infection in burns and other surgical wounds. Effective compounds possess certain chemical and physical properties. Prerequisites include low solubility, slow absorption, nonreactivity with wound exudates, proteins and ions and ability to achieve prolonged antimicrobial activity in the wound. These compounds yield much higher levels in the zone of infection than can be achieved by diffusion into the wound after systemic administration. The wide spectrum of antibacterial activity, the low toxicity, minimal tissue reaction, ease of application suggest that topical silver sulfadiazine therapy can safely be extended to other wound infections, wound covers and certain transplant materials.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000818:Animals; D002056:Burns / Q000188:drug therapy; D004269:DNA, Bacterial / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D051379:Mice; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000517:prevention & control; D051381:Rats; D012837:Silver Sulfadiazine / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage*; D013449:Sulfonamides / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000188:drug therapy
D004269:DNA, Bacterial; D013449:Sulfonamides; D013411:Sulfadiazine; D012837:Silver Sulfadiazine